Navigation Links
Martek Announces First Quarter 2008 Financial Results
Date:3/5/2008

products with reasonable profit margins or those that the Company expects could have a strategic fit in the future.

Gross Margin and Operating Expenses

Gross margin for the first quarter of fiscal 2008 was 41.1%, an increase over both the 34.0% gross margin realized in the first quarter of fiscal 2007 and the 40.2% gross margin realized in the fourth quarter of 2007, which included a non-recurring property tax recovery that contributed approximately 1% to gross margin. This gross profit margin improvement resulted from DHA productivity gains at Martek's manufacturing facilities, as well as reductions in ARA costs.

Research and development expenses in the first quarter of fiscal 2008 were $6.0 million, essentially unchanged from the first quarter of fiscal 2007. The Company's research and development efforts continue to focus on developing new food and beverage applications for life'sDHA(TM), broadening the scientific evidence supporting the benefits of life'sDHA(TM) throughout life, improving manufacturing processes and developing new products to expand the Company's market offerings. The Company will experience quarter-to-quarter fluctuations in research and development expenses primarily due to the timing of outside services, including third-party clinical trial services.

During the first quarter of fiscal 2008, selling, general and administrative expenses increased to $13.0 million, a $2.3 million increase from last year's first quarter. As a percentage of revenue, the Company's selling, general and administrative expenses increased to 15.7% in the first quarter of fiscal 2008 from 15.1% in last year's first quarter. The Company continues to invest resources in areas needed to support its growth. Furthermore, Martek continues to incur costs for marketing initiatives, which vary based on the timing of such marketing campaigns, and which are mainly designed to increase sales to infant formula customers overseas and to grow DHA markets ou
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Marteks lifesDHA(TM) Featured in Three New Offerings of Baby Food from Plum Organics
2. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
3. Pocket Rocket Juice from Australias Boost Juice Features 700 mg of Marteks lifesDHA(TM)
4. Martek Announces Settlement of Class Action Lawsuit
5. Marteks lifesDHA(TM) Featured in Dalco Foods Wellness Line Meat Products
6. Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International
7. Martek Wins German DHA Patent Infringement Actions Against Lonza and One of Nutrinovas Customers in Suits Relating to DHA Product Marketed for Use in Functional Foods and Dietary Supplements
8. Marteks lifesDHA(TM) Featured in New Beech-Nut(R) DHA Plus Baby Food and Cereals
9. Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
10. Martek Announces Addition of lifesDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars
11. Martek Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , ... September 04, 2015 , ... ... the surrounding communities, is launching a charity effort to provide for the family ... to as an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction – ...
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar announced today ... meeting of its Product, Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. ... in the consumer goods industry, it can be difficult for companies to navigate, ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... separate “Partner of the Year” awards at this year’s Microsoft Worldwide Partner Conference ... 2015 “Partner of the Year” Award Winner for Data Platform services, the 2015 ...
(Date:9/4/2015)... ... September 04, 2015 , ... San Francisco cosmetic dentist ... CEREC is a newer method for creating restorations through innovative imaging equipment and ... the need for multiple appointments, CEREC produces restorations with total precision for a ...
(Date:9/4/2015)... ... September 04, 2015 , ... Mike Day, a former Navy ... compete in the Ironman World Championships in Kona on October 10th. , Mike is ... Brain Injury (TBI) through combat and the cutting-edge treatments that restore their quality of ...
Breaking Medicine News(10 mins):Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2
... Scientists hope to make it available online, BOSTON, ... discovered a simple and inexpensive way for patients with,retinal ... in their vision,loss. In a study published in this ... compelling visual illusion known as the induced twinkle,after-effect (TAE) ...
... 24 Caraco Pharmaceutical,Laboratories, Ltd. (Amex: CPD ) ... six months of fiscal 2008, ended September 30, 2007, ... $28.3 million,and $53.0 million for the corresponding periods of ... over second quarter and first six,months of fiscal 2007, ...
... Expenses ... for Medical Foods, NOVATO, Calif., ... that it has,provided a $250,000 grant to the National Organization for ... with,phenylketonuria (PKU), a rare genetic metabolic disorder. Funds from this,new program ...
... IRVINE, Calif., Oct. 24 CME LLC ... medical education programs,since 1978, today announced it has ... Association (APA) as an approved sponsor of,continuing medical ... the five-year full approval as part of the ...
... Calif., October 24, 2007 The Parkinsons Institute and ... treatment reduces medication-induced dyskinesias by as much as 50 ... senior research scientist, Maryka Quik, Ph.D., the research will ... of Neurology. , Levodopa, the most common ...
... 24 Anesiva,Inc. (Nasdaq: ANSV ) will announce ... close on Thursday, November 1, 2007 and will hold ... of Anesiva,s,management team will discuss financial results from the ... the company,s product pipeline, recent,events and milestones. Interested ...
Cached Medicine News:Health News:'Twinkle After-Effect' Can Help Retinal Patients Detect Vision Loss Quickly and Cheaply and Prevent Further Loss 2Health News:'Twinkle After-Effect' Can Help Retinal Patients Detect Vision Loss Quickly and Cheaply and Prevent Further Loss 3Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 2Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 3Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 4Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 5Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 6Health News:Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008 7Health News:BioMarin Provides Grant to NORD to Expand PKU Patient Support Services 2Health News:BioMarin Provides Grant to NORD to Expand PKU Patient Support Services 3Health News:BioMarin Provides Grant to NORD to Expand PKU Patient Support Services 4Health News:BioMarin Provides Grant to NORD to Expand PKU Patient Support Services 5Health News:CME LLC Granted Five-Year Full Approval by the American Psychological Association 2Health News:Parkinson's Institute research shows that nicotine reduces levodopa-induced dyskinesias 2Health News:Anesiva to Announce Third Quarter 2007 Financial Results and Host Webcast Conference Call on November 1, 2007 2
(Date:9/3/2015)... Report Details Ovarian Cancer ... Changes and Emerging Opportunities What,s the future for ... study forecasts those pharmaceutical revenues. There you find ... also explore trends, results, treatments, R&D, and opportunities, ... predictions to 2025 at overall world market, submarket, ...
(Date:9/3/2015)... Sept. 3, 2015 With a population of ... country and therefore also its single largest potential market ... China has led all major world economies in the ... expenditures, and government health expenditures. As an in vitro ... markets of the United States, western European countries, and ...
(Date:9/3/2015)... 2015 About artificial organs ... are implanted or integrated into individuals to ... artificial heart, kidney, pancreas, and cochlear implants. ... and porous polypropylene), biologics, ceramics, and metals ... organs are incorporated with different technologies like ...
Breaking Medicine Technology:Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Global Artificial Organ Market 2015-2019 2
... Scientific Corporation (NYSE: BSX ) today ... OMEGA™ Platinum Chromium Bare-Metal Coronary Stent System, the ... Scientific,s unique platinum chromium (PtCr) alloy designed specifically ... interventional cardiologists with a bare-metal stent with improved ...
... Unilife Corporation ("Unilife" or the "Company") (Nasdaq: UNIS ... at Cowen and Company,s 31st Annual Health Care Conference being ... Shortall, Chief Executive Officer of Unilife, is scheduled to present ... The conference presentation will be broadcast over the Internet ...
Cached Medicine Technology:Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System 2Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System 3Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System 4Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston 2
... pacemaker family offers some ... automatic devices. Featuring the ... advanced technologies ever seen, ... incorporates the exclusive ventricular ...
... The SPOTCHEM EZ is a small bench ... Testing is performed on reagent strips with results ... is 48 tests per hour. The instrument accepts ... the swipe of a magnetic card. At the ...
... Veriteq's Refrigerator and Freezer Monitoring ... monitoring system for refrigerators and ... install. Using a building's existing ... Freezer monitoring solution automates the ...
The ThermaViewer™ is constructed and engineered for use in laboratories, hospitals, and commercial kitchens to monitor and document freezer and refrigerator temperatures where inventory is store...
Medicine Products: